This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

This study has been terminated.
(Terminated due to limited enrollment and follow up.)
Information provided by (Responsible Party):
DePuy Orthopaedics Identifier:
First received: March 23, 2006
Last updated: December 1, 2011
Last verified: December 2011
Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty

Condition Intervention Phase
Osteoarthritis Rheumatoid Arthritis Post-traumatic Arthritis Avascular Necrosis Acute Fracture Device: non-coated femoral hip stem Device: coated femoral hip stem Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Prospective, Randomized Study of Summit™ Porocoat® Versus Summit™ DuoFix™ HA in Cementless Total Hip Arthroplasty

Resource links provided by NLM:

Further study details as provided by DePuy Orthopaedics:

Primary Outcome Measures:
  • Harris Hip Score (HHS) [ Time Frame: Preoperative, 6, 12, 24, 36, 48, and 60 months ]
    The Harris Hip scoring system assigns a numeric value to responses from patients and assessments made by a surgeon. A score of 90-100 is excellent, 80-90 is good, 70-80 is fair, 60-69 is poor, and 60 or below is failed. The patient records the following: pain level, need for assistance when walking, presence of a limp, distance able to walk, ability to put on shoes and socks, climb stairs, use public transportation and the length of time one is able to comforatably sit in a chair are all scored. The doctor assesses patient hip function by testing flexion, extension, adduction and abduction.

Secondary Outcome Measures:
  • Medical Imaging [ Time Frame: postoperative, 6, 12, 24, 36, 48 and 60 months ]

Enrollment: 245
Study Start Date: November 2002
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
DuoFix HA
Device: non-coated femoral hip stem
total hip replacement
Other Name: Summit DuoFix HA hip stem
Active Comparator: 2
Porocoat porous coated
Device: coated femoral hip stem
total hip replacement
Other Name: Summit Porocoated porous coated hip stem.

Detailed Description:
Hydroxyapatite (HA) is a bioactive ceramic that resembles the natural inorganic mineral content of bone, and as such is a highly osteoconductive material. The purpose of this study is to compare an HA coated and uncoated prosthesis.

Ages Eligible for Study:   up to 75 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary total hip replacement
  • Patient age less than or equal to 75
  • Sufficient bone stock to support prosthesis

Exclusion Criteria:

  • Previous hip replacement
  • Significant angular/bony deformity
  • Active joint sepsis
  • Metal allergy
  • Renal transplant
  • Psychosocial disease
  • Neurological disease/musculoskeletal disease that may affect weight-bearing
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00306917

United States, Indiana
DePuy Orthopaedics
Warsaw, Indiana, United States, 46581
Sponsors and Collaborators
DePuy Orthopaedics
Principal Investigator: David A Fisher, MD Orthopaedics Indianapolis
Principal Investigator: J W Mesko, MD Michigan Orthopaedics Center
Principal Investigator: Paul Perona, MD St Margaret's Hospital Family Orthopaedics
Principal Investigator: Stephan B Lowe, MD Orthopaedic Specialists of the Carolinas
Principal Investigator: Donald L Pomeroy, MD Pomeroy & Reddy
Principal Investigator: Nithin Reddy, MD Pomeroy & Reddy
  More Information

Responsible Party: DePuy Orthopaedics Identifier: NCT00306917     History of Changes
Other Study ID Numbers: SPD
Study First Received: March 23, 2006
Results First Received: January 29, 2010
Last Updated: December 1, 2011

Keywords provided by DePuy Orthopaedics:
Total Hip Replacement

Additional relevant MeSH terms:
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes processed this record on June 23, 2017